Natural Product Sciences

  • 제23권3호
  • /
  • Pages.169-174
  • /
  • 2017
  • /
  • 1226-3907(pISSN)
  • /
  • 2288-9027(eISSN)
한국생약학회 (The Korean Society of Pharmacognosy)
권호 표지
DOI QR코드

DOI QR Code

Quercetin Relaxed the Smooth Muscle of Rabbit Penile Corpus Cavernosum by Activating the NO-cGMP Signaling Pathway

  • Choi, Bo Ram (Department of Urology, Chonbuk National University and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University) ;
  • Kim, Hye Kyung (College of Pharmacy, Kyungsung University) ;
  • Park, Jong Kwan (Department of Urology, Chonbuk National University and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University)
  • 투고 : 2017.04.10
  • 심사 : 2017.05.08
  • 발행 : 2017.09.29
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The aim of this study was to investigate the effect and action mechanism of quercetin on penile corpus cavernosum smooth muscle (PCCSM). PCCSM precontracted with phenylephrine (Phe) was treated with four different concentrations of quercetin ($10^{-7}$, $10^{-6}$, $10^{-5}$ and $10^{-4}M$). PCCSM were preincubated with N-Nitro-L-arginine methyl ester hydrochloride (L-NAME) and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to block nitric oxide synthase and guanylate cyclase, respectively. The changes in PCCSM tension were recorded, and cyclic nucleotides in the perfusate were measured by radioimmunoassay. The interactions of quercetin with phosphodiesterase type 5 inhibitors (PDE5-Is) such as sildenafil, udenafil and mirodenafil, were also evaluated. PCCSM relaxation induced by quercetin occurred in a concentrationdependent manner. The application of quercetin to PCCSM pre-treated with L-NAME and ODQ significantly inhibited the relaxation. Quercetin significantly increased cGMP in the perfusate. Furthermore, quercetin enhanced PDE5-Is-induced relaxation of PCCSM. Quercetin relaxed the PCCSM by activating the NO-cGMP signaling pathway, and it may be a therapeutic candidate or an alternative treatment for patients with erectile dysfunction who do not completely respond to PDE5-Is.

키워드

참고문헌

  1. Kouidrat, Y.; Zaitouni, A.; Amad, A.; Diouf, M.; Desailloud, R.; Loas, G.; Lalau, J. D. J. Diabetes Complicat. 2017, 31, 108-113. https://doi.org/10.1016/j.jdiacomp.2016.10.026
  2. Sheweita, S. A.; Wally, M.; Hassan, M. Oxid. Med. Cell Longev. 2016, 2016, 1-9.
  3. Matos, G.; Hirotsu, C.; Alvarenga, T. A.; Cintra, F.; Bittencourt, L.; Tufik, S.; Andersen, M. L. Andrology 2013, 1, 872-878. https://doi.org/10.1111/j.2047-2927.2013.00136.x
  4. Hatzichristou, D.; Rosen, R. C.; Broderick, G.; Clayton, A.; Cuzin, B.; Derogatis, L.; Litwin, M.; Meuleman, E.; O'Leary, M.; Quirk, F.; Sadovsky, R.; Seftel, A. J. Sex. Med. 2004, 1, 49-57. https://doi.org/10.1111/j.1743-6109.2004.10108.x
  5. Chiou, W. F.; Chen, C. F. Eur. J. Pharmacol. 2002, 446, 151-159. https://doi.org/10.1016/S0014-2999(02)01762-4
  6. Sullivan, M. E.; Thompson, C. S.; Dashwood, M. R.; Khan, M. A.; Jeremy, J. Y.; Morgan, R. J.; Mikhailidis, D. P. Cardiovasc. Res. 1999, 43, 658-665. https://doi.org/10.1016/S0008-6363(99)00135-2
  7. Deng, W.; Bivalacqua, T. J.; Hellstrom, W. J. G.; Kadowitz, P. J. Int. J. Impot. Res. 2005, 17, S57-S63. https://doi.org/10.1038/sj.ijir.3901430
  8. Yan, L.; Zhang, J. D.; Wang, B.; Lv, Y. J.; Jiang, H.; Liu, G. L.; Qiao, Y.; Ren, M.; Guo, X. F. PLoS One 2013, 8, 1-14.
  9. Bhutada, P.; Mundhada, Y.; Bansod, K.; Bhutada, C.; Tawari, S.; Dixit, P.; Mundhada, D. Neurobiol. Learn. Mem. 2010, 94, 293-302. https://doi.org/10.1016/j.nlm.2010.06.008
  10. Ranawat, P.; Pathak, C. M.; Khanduja, K. L. Phytother. Res. 2013, 27, 802-810. https://doi.org/10.1002/ptr.4799
  11. Senggunprai, L.; Kukongviriyapan, V.; Prawan, A.; Kukongviriyapan, U. Phytother. Res. 2014, 28, 841-848. https://doi.org/10.1002/ptr.5061
  12. Erden Inal, M.; Kahraman, A. Toxicology 2000, 154, 21-29. https://doi.org/10.1016/S0300-483X(00)00268-7
  13. Chen, C. K.; Pace-Asciak, C. R. Gen. Pharmacol. 1996, 27, 363-366. https://doi.org/10.1016/0306-3623(95)02001-2
  14. Zhao, C.; Chae, H. J.; Kim, S. H.; Cui, W. S.; Lee, S. W.; Jeon, J. H.; Park, J. K. J. Sex. Med. 2010, 7, 1419-1428. https://doi.org/10.1111/j.1743-6109.2009.01652.x
  15. Cui, X.; Lee, S. J.; Kim, S. Z.; Kim, S. H.; Cho, K. W. Eur. J. Pharmacol. 2000, 402, 129-137. https://doi.org/10.1016/S0014-2999(00)00514-8
  16. Li, X.; Oh, H. C.; Son, S. B.; Lee, Y. J.; Kang, D. G.; Lee, H. S. Evid. Based Complement. Alternat. Med. 2012, 2012, 1-10.
  17. Feng, X. T.; Qin, C. B.; Leng, J.; Tang, Q. L.; Shi, H.; Zhai, L. N.; Li, S. L. Biosci. Biotechnol. Biochem. 2012, 76, 257-263. https://doi.org/10.1271/bbb.110568
  18. Nimmegeers, S.; Sips, P.; Buys, E.; Decaluwe, K.; Brouckaert, P.; Van de Voorde, J. Int. J. Impot. Res. 2008, 20, 278-284. https://doi.org/10.1038/sj.ijir.3901627
  19. Eardley, I. Br. J. Diabetes Vasc. Dis. 2002, 2, 272-276. https://doi.org/10.1177/14746514020020040701
  20. Hosogai, N.; Takakura, S.; Manda, T.; Mutoh, S. Eur. J. Pharmacol. 2003, 473, 65-70. https://doi.org/10.1016/S0014-2999(03)01947-2
  21. Choi, B. R.; Kumar, S. K.; Zhao, C.; Zhang, L. T.; Kim, C. Y.; Lee, S. W.; Jeon, J. H.; Soní, K. K.; Kim, S. H.; Park, N. C.; Kim, H. K.; Park, J. K. Int. J. Impot. Res. 2015, 27, 225-232. https://doi.org/10.1038/ijir.2015.23